Navigation Links
Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
Date:5/23/2013

.

Elan is incorporated under the laws of Ireland.  Some of the directors of Elan are resident in countries other than the United States.  As a result, it may not be possible for United States holders of Elan Stock to effect service of process within the United States upon Elan or such directors of Elan or to enforce against any of them judgements of the United States predicated upon the civil liability provisions of the federal securities laws of the United States.  It may not be possible to sue Elan or its officers or directors in a non-US court for violations of US securities laws.  In addition, US holders of Elan Stock should be aware that, if Royalty Pharma elects to proceed pursuant to a scheme of arrangement (as described in the Original Offer Document and to be described in the Revised Offer Document), the federal securities laws of the United States may not be applicable.

Additional Information

Any response in relation to the Increased Offer (including any acceptance thereof) should be made only on the basis of the information contained in the Revised Offer Document, the Revised Acceptance Documents or any other document by which the Increased Offer is made. Royalty Pharma reserves the right, with the consent of the Irish Takeover Panel, to elect to implement the acquisition of Elan by way of court-approved scheme of arrangement under Section 201 of the Companies Act 1963 of Ireland.

Responsibility Statements

The directors of Royalty Pharma accept responsibility for the information contained in this announcement, save that the only responsibility accepted by the directors of Royalty Pharma in respect of the information in this announcement relating to Elan, the Elan Group, the Board of Elan and the persons connected with them, which has been compiled from published sources, ha
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Royalty Rates Take Center Stage in Biopharma Dealmaking
2. Royalty Pharma Announces Proposal To Acquire Elan
3. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
4. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
5. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
6. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
7. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
8. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
9. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
10. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
11. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... and ALISO VIEJO, Calif. ... (NYSE: AGN ), a leading global pharmaceutical ... medical device company focused on developing ocular implants ... today announced that they have entered into an ... an all-cash transaction.  Under the terms of the ...
(Date:9/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/twqfk6/global_medical ) has announced ... Market - By Packaging type, Regions and Vendors - ... to their offering. The growth of ... end use industry, i.e., Medical devices industry. More innovations ... so as to be tamper evident, and child-resistant. The ...
(Date:9/3/2015)... , Sep. 03, 2015 ... of the "Investigation Report on China,s Entecavir Market, ... number of people infected with hepatitis B virus (HBV) ... among which 20-30 million suffering from chronic Hepatitis B. ... liver damage and liver cancer caused by chronic Hepatitis ...
Breaking Medicine Technology:Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 3Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 4Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 5Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 6Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 2Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 3Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 4Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 5Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 6Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 7Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 8China Entecavir Market Report 2010-2019 2
... of once-daily TMC278 in ... treatment-naive adults with HIV-1 -, ... from Tibotec,Pharmaceuticals Ltd. provides additional information on the safety ... inhibitor (NNRTI), as part of HIV,combination therapy in treatment-naive ...
... CAMBRIDGE, Mass., Aug. 5 Tolerx, Inc., a,biopharmaceutical ... novel,therapies for the treatment of immune-mediated diseases, announced ... version of TRX1,MTRX1011A, an anti-CD4 monoclonal antibody, into ... patients. The clinical trial is evaluating the,safety and ...
Cached Medicine Technology:Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 3
(Date:9/4/2015)... ... September 04, 2015 , ... ... assistance company today announced that it has entered into a multi-year agreement with ... an agreement to bridge the link between American healthcare, Jamaican healthcare and Health ...
(Date:9/3/2015)... ... September 03, 2015 , ... TransPack Toon gives users a set of ... wipes and framing transitions in 30 different styles. Presets range from snow, underwater, forest, ... X. , TransPack Toon features 90 cartoon transitions from 30 unique styles. Editors ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... in Patient Experience Conference 2016, to be held April 13-15 at Sheraton Hotel ... hosted event bringing together the collective voices of healthcare leaders, staff, physicians, patients ...
(Date:9/3/2015)... ... September 03, 2015 , ... Results of a comprehensive survey ... and Policy Analysis has found physician leadership development training programs to be growing ... respondents said their organizations conduct some kind of physician leadership development program, another ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... graduated compression garments. However, graduated compression garments are an effective solution for reducing ... specialist, Robyn Bjork, was recently sponsored by SIGVARIS for a unique ...
Breaking Medicine News(10 mins):Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6Health News:Pixel Film Studios Releases TransPack Toon, a New FCPX Transition 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 3Health News:Survey finds growing movement for physician leadership training 2Health News:Survey finds growing movement for physician leadership training 3Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3
... and adolescents growing up with inflammatory bowel disease (IBD) are ... at McMaster University and the McMaster Children,s Hospital. The ... shows children and youth with the most common forms of ... lower than other children their age, and their muscle function ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, March ... pack or more a day has dropped significantly in the United ... finds. The number of people smoking less than a pack ... added the researchers, who examined national data on smoking rates from ...
... WEDNESDAY, March 16 (HealthDay News) -- College students are less ... if their parents monitor their social lives, researchers have ... parenting style and the link is stronger with the parent ... published in the March issue of the Journal of ...
... Older adults may put themselves at risk by talking on ... new study. The researchers found that adults aged 59 to ... simulated street while talking on a mobile phone, and their ... safety. Older adults on cell phones also were more likely ...
... 16, 2011An estimated nine million working-age adults57 percent of people ... uninsured in the last two years, according to the Commonwealth ... paints a bleak picture for the 43 million adults under ... a job in the past two years, finding that job ...
... of choice for treating severe malaria, according to an updated ... the antimalarial drug artesunate, which is derived from herbs used ... patients with severe malaria. Severe malaria occurs when ... associated with rarer cerebral malaria, which affects the brain and ...
Cached Medicine News:Health News:Youth with IBD are less fit than their peers: McMaster study 2Health News:Heavy Smoking Declines in U.S. 2Health News:Heavy Smoking Declines in U.S. 3Health News:Parents Can Help Prevent Problem Drinking in College Kids 2Health News:New health insurance survey: 9 million adults joined ranks of uninsured due to job loss in 2010 2Health News:New health insurance survey: 9 million adults joined ranks of uninsured due to job loss in 2010 3Health News:New health insurance survey: 9 million adults joined ranks of uninsured due to job loss in 2010 4Health News:New health insurance survey: 9 million adults joined ranks of uninsured due to job loss in 2010 5Health News:Newer antimalarials more effective than quinine against severe malaria 2
The Nine West Eyewear collection is positioned to present today's styles with a sharp, edgy contemporary attitude tied into a clean design element....
The Liz Claiborne eyewear collection features feminine, classic, progressive friendly designs that meet the needs of today's women. The high quality frames are modern, but not trendy....
Inquire...
... inspired by the professional male who enjoys buying ... by all men especially those between the ages ... complete range of materials, shapes and colors. Classic ... the best that fashion and technology has to ...
Medicine Products: